Related by context. Frequent words. (Click for all words.) 58 BioLineRx 57 FDA Accepts 56 Marketing Authorisation 56 Australian Therapeutic Goods 55 Kuvan R 55 D Pharm 55 Orphan Drug status 55 Presents Positive 54 Rosetta Genomics Ltd. 54 Giza Venture 54 Application MAA 53 GammaCan 53 Application BLA 53 Panzem R 53 Patent Covering 53 submitted Biologics License 53 Positive Opinion 53 Compugen Ltd. 53 NV Organon 53 Initiate Phase 53 Clinical Trial Application 53 Recombinant Human 52 Pivotal Phase III 52 Fast Track Designation 52 IND Investigational New 52 Orphan Drug Status 52 Neopharm 52 Exclusive License 52 Protalix BioTherapeutics 52 Rotarix R 52 Idera Pharmaceuticals 52 Ceragenix 52 Orphan Drug designation 52 refractory chronic lymphocytic 52 Gamida Cell 51 Onalta 51 supplemental Biologics License Application 51 Initiates Phase 51 Develop Novel 51 GlaxoSmithKline plc GSK 51 Archemix Corp. 51 DeveloGen 51 ATryn ® 51 OTCQX RHHBY 51 Argatroban 51 Ampligen r 51 FDA Clears 51 Inc. Nasdaq SEPR 51 Marketing Authorization 51 Loramyc R 51 taliglucerase alfa 50 Files Shelf Registration Statement 50 Completes Enrollment 50 TLR9 agonist 50 Announces Initiation 50 Merrimack Pharmaceuticals 50 Hadasit 50 BioCancell 50 ImmunoCellular Therapeutics 50 Investigational Device Exemption 50 Elafin 50 Welfare MHLW 50 DAVANAT ® 50 Kineret 50 Cetrorelix 50 Generic Version 50 Ltd. Nasdaq TEVA 50 Portola Pharmaceuticals 50 Junovan 50 Enzymotec 49 faropenem 49 Signs Licensing Agreement 49 Generex Oral lyn 49 Biologics License Application 49 topical anti infective 49 Teva Pharma 49 Single Dose 49 Acquires Exclusive 49 NASDAQ TEVA 49 R sorafenib tablets 49 Plenaxis R 49 Announces FDA Clearance 49 ISTODAX 49 NASDAQ CRXL 49 nonexclusive license 49 ViaCyte 49 Ltd. TASE 49 Receives FDA Clearance 49 VALSTAR 49 Multiferon R 48 Receives Regulatory 48 Ltd. TEVA 48 Globes Tel Aviv 48 Swissmedic 48 subcutaneous formulation 48 Combidex 48 Inc. Nasdaq MYL 48 Regains Compliance 48 Receives Patent 48 Pennsaid R 48 NASDAQ SHPGY